Table 5.
Clinical outcomes across all patients with eFONA.
| Setting | Number of patients (number of studies) | Clinical outcome |
|---|---|---|
| Survival to hospital admission | ||
| Pre-hospital | 195 (seven studies)11, 17, 19, 21, 27, 30, 32 | 29% (range 19–91%) |
| In-hospital | 49 (One study)39 | 73% |
| Pre-hospital and in-hospital | NA | NA |
| Battlefield | 127 (Three studies)69, 71, 74 | 53% (range 46–55%) |
| Survival to hospital discharge/30-days | ||
| Pre-hospital | 423(Seven studies)10, 15, 17, 22, 24, 27, 32 | 64% (range 7–98%) |
| In-hospital | 255 (Eight studies)38, 40, 41, 46, 47, 48 | 42% (range 13–82%) |
| Pre-hospital and in-hospital | 227 (Six studies) 54, 60, 57, 58 | 32% (range 27–75%) |
| Battlefield | 692 (Seven studies)67, 68, 70, 73, 74, 76, 77 | 45% (range 4–67%) |
| Survival to hospital discharge/30-days with good functional outcome | ||
| Pre-hospital | 77 (Three studies)10, 15, 24 | 5% (range 0–27%) |
| In-hospital | 158 (Four studies)36, 43, 46, 47 | 44% (range 5–69%) |
| Pre-hospital and in-hospital | 112 (Two studies)58, 63 | 33% (range 29–34%) |
| Battlefield | 34 (One study)77 | 9% |